Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.
About 63% of American adults consume at least one or more sugar-sweetened beverages daily.
For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
Colorectal cancer often spreads to the liver, especially when patients have fatty liver disease. New research may help explain this link.
People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.
VK2809 and pegozafermin are among several medications coming through the pipeline for fatty liver disease
Disturbed gut bacteria may contribute to slower tissue regeneration after liver surgery or other injury.
A second meta-analysis found that people with cirrhosis had higher COVID mortality.
Individuals with fatty liver disease were more likely to need daytime naps and sleeping pills.
The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.
People with advanced fibrosis—not just cirrhosis—were at greater risk for hepatocellular carcinoma.
Researchers suggest cannabis use alone should not be a reason to deny transplants.
Some 20% of those with NAFLD also showed signs of liver fibrosis.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Positive results announced by Madrigal Pharmaceuticals could potentially lead to the first drug approval for fatty liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.